Lucid Diagnostics Inc. (LUCD)
LUCD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.6060
+1.44% on the day
Market cap
$123.2M
Micro cap
Revenue · 2024
$4.3M
+79.0% on 2023
Net income · 2024
-$45.5M
-1047.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | LUCD on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001799011 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $4.3M |
| Net income | -$45.5M |
| Operating income | -$46.1M |
| Net margin | -1047.6% |
| Operating margin | -1059.6% |
| Revenue growth | +79.0% |
| Cash | $22.4M |
| Total assets | $30.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 28.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-04-23 |
| Latest annual report FORM 10-K | 10-K | 2026-03-25 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-09-22 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 279 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NYXH | Nyxoah SA | $1.28 | -2.29% | $128.1M |
| SKYA | SkyAI Inc. | $2.61 | +0.39% | $112.9M |
| APYX | Apyx Medical Corporation | $2.60 | -1.89% | $109.5M |
| KRMD | KORU Medical Systems Inc. Common Stock (DE) | $3.00 | +1.01% | $138.5M |
| STIM | Neuronetics Inc. | $1.99 | -6.57% | $151.6M |
| PYPD | PolyPid Ltd. | $4.88 | -2.79% | $99.1M |
| QTEX | QTREX Quantum Ltd. | $1.58 | 0.00% | $88.4M |
| LNSR | LENSAR Inc. | $6.27 | +0.80% | $77.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier